Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115731) titled 'The effects of colchicine on the prognosis of the patients with coronary artery spasm and its mechanisms' on Dec. 30, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First People's Hospital of Nantong
Condition:
coronary artery spasm
Intervention:
Colchicine Group:Colchicine 0.5 mg qd.
Conventional Treatment Group:Placebo 0.5 mg qd.
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 2022-01-10
Target Sample Size: Colchicine Group:100;Conventional Treatment Group:100;Control Group:100;
Countries of Recruitment:
China
To know more, visit https:/...